FY22 Investor Presentation

CASHFLOW STATEMENT FY22 (Underlying)* (Pre AASB16)^ $3.85m FY22 (Statutory) (Post AASB16) $5.69m FY21 (Statutory) (Post AASB16) $6.37m EBITDA Change in net working capital Net interest Paid Net Cashflow from Operating Activities Purchase of property, plant and equipment Purchase of intangibles Deposit for bank guarantees Net Loans to other entities $1.03m $1.34m ($0.23m) ($0.24m) ($0.43m) ($0.98m) $4.64m $6.60m $4.64m ($0.97m) ($0.97m) ($0.24m) ($0.32m) ($0.32m) $- ($0.01m) ($0.01m) $- ($0.71m) ($0.71m) ($0.22m) Net cash received on disposal of asset group $0.49m $0.49m $2.62m Net cash (used in) / received from investing activities ($1.52m) ($1.52m) $2.16m Payment of principal portion of lease liabilities Proceeds from borrowings $- Repayment of borrowings Proceeds from exercise of options $- Share issue costs ÉÀ ÉÀ ÉÀ ÉÀ É $- ($1.96m) ($1.92m) $- $5.00m $- ($7.84m) $- $- $0.39m ($0.06m) Net cash used in financing activities ($1.96m) ($4.42m) Net increase in cash and cash equivalents held $3.12m $3.12m $2.37m Cash and cash equivalents at the beginning of the year $5.10m $5.10m $2.72m Cash and cash equivalents at the end of the year $8.22m $8.22m $5.10m Underlying EBITDA adjusted for the impact of AASB16 ^ This is a non A-IFRS measure Note - may not add through due to rounding differences 26 FY22 Investor Presentation 26

View entire presentation